American River Nutrition’s GG-Gold ingredient gets GRAS self-determination
American River Nutrition’s GG-Gold ingredient containing geranylgeraniol (GG) has been self-determined to be Generally Recognized as Safe (GRAS) for food and beverage use.
Photo © iStockphoto.com/angelhell
American River Nutrition’s (Hadley, MA) GG-Gold ingredient containing geranylgeraniol (GG) has been self-determined to be Generally Recognized as Safe (GRAS) for food and beverage use by an independent panel of experts at AIBMR Life Sciences (Seattle, WA). GG is present both in the body as well as naturally in foods such as flax, sunflower, and olive oil. In humans, it is key to the production of CoQ10 and vitamin K2 MK-4, and plays a role in muscle protein synthesis. Levels of GG, as well as CoQ10, can decrease with statin use.
American River Nutrition’s GG-Gold ingredient is derived from the tropical annatto plat. Barrie Tan, PhD, the company’s founder and president, said in a press release, “Considering the essential nature of this compound, we see the application of GG-Gold in a broad array of healthy-aging protocols, including utilization in functional food and beverages. We have engaged and plan to continue research in the cardiovascular health and antiaging platforms…” The company offers GG-Gold as an oil concentrate and a cold-water-dispersible powder for inclusion in food and drink, including in combination with CoQ10 in products for heart health.
Tan says American River Nutrition is the first company in the world to produce the critical GG nutrient commercially.
DOJ asks Utah court to dismiss FTC lawsuit against Xlear Inc.
March 11th 2025On March 10, the DOJ and the defendant filed a stipulation to dismiss with prejudice the lawsuit in which each party agrees “to be responsible for its own costs and fees and agrees that no party shall be responsible to any other party for any fines, costs, fees, or penalties arising from this case.”
HHS announces efforts to eliminate independent conclusion of GRAS
Published: March 11th 2025 | Updated: March 11th 2025U.S. Department of Health and Human Services (HHS) Secretary, Robert F. Kennedy Jr., is directing the acting U.S. Food and Drug Administration’s (FDA) acting commissioner to explore rulemaking that would eliminate the independent conclusion of GRAS provision.
